Overview
Familial Alzheimer-like prion disease (Orphanet code 280397) is an extremely rare inherited prion disease (transmissible spongiform encephalopathy) caused by mutations in the PRNP gene, which encodes the prion protein. Unlike typical Alzheimer disease, this condition is classified among prion diseases, but it presents with clinical and neuropathological features that closely mimic Alzheimer disease, including progressive dementia, memory loss, and cognitive decline. The brain is the primary organ affected, with neurodegeneration characterized by spongiform changes, neuronal loss, and the accumulation of abnormal prion protein. Notably, affected individuals may also show amyloid plaques and neurofibrillary tangles reminiscent of Alzheimer disease, which can complicate the clinical and pathological distinction between the two conditions. The disease follows an autosomal dominant inheritance pattern, meaning that a single copy of the mutated PRNP gene inherited from an affected parent is sufficient to cause the condition. Onset typically occurs in adulthood, and the disease is progressive, leading to severe cognitive impairment, behavioral changes, and eventually death. Additional neurological features may include myoclonus, ataxia, and psychiatric symptoms such as depression or personality changes. Diagnosis is supported by genetic testing for PRNP mutations, neuroimaging, and cerebrospinal fluid biomarkers, though definitive diagnosis may require neuropathological examination. There is currently no cure or disease-modifying treatment for familial Alzheimer-like prion disease. Management is supportive and symptomatic, focusing on maintaining quality of life, managing behavioral and psychiatric symptoms, and providing palliative care as the disease progresses. Genetic counseling is recommended for affected families to discuss the implications of autosomal dominant inheritance and the availability of predictive genetic testing for at-risk relatives.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Familial Alzheimer-like prion disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Familial Alzheimer-like prion disease at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Familial Alzheimer-like prion disease.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Familial Alzheimer-like prion disease.
Community
No community posts yet. Be the first to share your experience with Familial Alzheimer-like prion disease.
Start the conversation →Latest news about Familial Alzheimer-like prion disease
No recent news articles for Familial Alzheimer-like prion disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Familial Alzheimer-like prion disease
What is Familial Alzheimer-like prion disease?
Familial Alzheimer-like prion disease (Orphanet code 280397) is an extremely rare inherited prion disease (transmissible spongiform encephalopathy) caused by mutations in the PRNP gene, which encodes the prion protein. Unlike typical Alzheimer disease, this condition is classified among prion diseases, but it presents with clinical and neuropathological features that closely mimic Alzheimer disease, including progressive dementia, memory loss, and cognitive decline. The brain is the primary organ affected, with neurodegeneration characterized by spongiform changes, neuronal loss, and the accum
How is Familial Alzheimer-like prion disease inherited?
Familial Alzheimer-like prion disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Familial Alzheimer-like prion disease typically begin?
Typical onset of Familial Alzheimer-like prion disease is adult. Age of onset can vary across affected individuals.